Britt B.M. Suelmann

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Jeroen van Dorp, Christodoulos Pipinikas, Britt B.M. Suelmann et al. · Nature Medicine · 2023 · 78 citations · Full text

Medicine, Oncology, Urology +10

Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients

Janneke Wiebolt, Roos Achterbergh, Ad den Boer et al. · European Journal of Endocrinology · 2011 · 54 citations

Life Sciences, Endocrinology, Immunology +14

Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study

Marije Koks, Gürbey Ocak, Britt B.M. Suelmann et al. · PLoS ONE · 2021 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile

Britt B.M. Suelmann, Carmen van Dooijeweert, Elsken van der Wall et al. · Breast Cancer Research and Treatment · 2021 · 44 citations · Full text

Medicine, Oncology, Pathology +12